CD7 Antibodies

Santa Cruz Biotechnology features a diverse variety of CD7 Antibodies for research in immunology and cell biology. CD7 monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CD7 is a glycoprotein expressed on the surface of T cells and some other immune cells, playing a crucial role in T cell activation and differentiation. It is involved in the regulation of immune responses and is important for maintaining the integrity of the immune system. The study of CD7 is essential for understanding various immune-related diseases and conditions, including leukemias and lymphomas. CD7 monoclonal antibodies enable researchers to explore cellular signaling pathways and molecular interactions in immune cell development. Understanding CD7's role in immune system regulation can lead to breakthroughs in therapeutic strategies for immunological disorders. CD7 monoclonal antibodies from Santa Cruz Biotechnology support researchers worldwide in advancing immunological research and developing potential treatments for immune-related diseases.